Everlife Asia Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1,000

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 5

  • Investments
  • 8

Everlife Asia General Information

Description

Operator of a market access and distribution company intended to serve the healthcare and research industries. The company invests in manufacturers and distributors in the region, covering key strategic segments including in-vitro diagnostics, medical diagnostics, critical care equipment, implants and consumables, enabling clients to have easy access to the fragmented markets of Asia.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Winsland House II,163 Penang Road
  • Level 06, Unit Number 02
  • Singapore, 238463
  • Singapore
+65 6511
Primary Industry
Diagnostic Equipment
Other Industries
Holding Companies
Parent Company
Integris Medtech
Corporate Office
  • Winsland House II,163 Penang Road
  • Level 06, Unit Number 02
  • Singapore, 238463
  • Singapore
+65 6511

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Everlife Asia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Everlife Asia‘s full profile, request access.

Request a free trial

Everlife Asia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Everlife Asia Investments (8)

Everlife Asia’s most recent deal was a Buyout/LBO with Neoscience (Biotechnology). The deal was made on 01-Jun-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Neoscience (Biotechnology) 01-Jun-2025 Buyout/LBO Biotechnology
Hausen Bernstein 01-Mar-2024 Buyout/LBO Distributors/Wholesale
Biofrontier Techonology 19-Jul-2022 Buyout/LBO Diagnostic Equipment
Research Instruments Group 10-Mar-2022 Buyout/LBO Distributors (Healthcare)
Analisa Resources 01-Jan-2022 Buyout/LBO Distributors/Wholesale
You’re viewing 5 of 8 investments. Get the full list »

Everlife Asia Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
Neoscience (Biotechnology) Petaling Jaya, Malaysia 2012
Hausen Bernstein Bangkok, Thailand 2003
Biofrontier Techonology Singapore, Singapore 2003
Analisa Resources Shah Alam, Malaysia 1999
Everlife Chemoscience Petaling Jaya, Malaysia 1975

Everlife Asia FAQs

  • When was Everlife Asia founded?

    Everlife Asia was founded in 2014.

  • Where is Everlife Asia headquartered?

    Everlife Asia is headquartered in Singapore, Singapore.

  • What is the size of Everlife Asia?

    Everlife Asia has 1,000 total employees.

  • What industry is Everlife Asia in?

    Everlife Asia’s primary industry is Diagnostic Equipment.

  • Is Everlife Asia a private or public company?

    Everlife Asia is a Private company.

  • What is the current valuation of Everlife Asia?

    The current valuation of Everlife Asia is .

  • What is Everlife Asia’s current revenue?

    The current revenue for Everlife Asia is .

  • How much funding has Everlife Asia raised over time?

    Everlife Asia has raised $5.5M.

  • When was Everlife Asia acquired?

    Everlife Asia was acquired on 12-Jun-2025.

  • Who acquired Everlife Asia?

    Everlife Asia was acquired by Integris Medtech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process